105
Participants
Start Date
April 20, 2018
Primary Completion Date
September 12, 2022
Study Completion Date
Liraglutide
No treatment given
Novo Nordisk Investigational Site, Soeborg
Lead Sponsor
Novo Nordisk A/S
INDUSTRY